1
by Santaguida, Pasqualina
Published 2004
U.S. Dept. of Health and Human Services, Public Health Service, Agency for Healthcare Research and Quality

2
by Santaguida, Pasqualina
Published 2004
U.S. Dept. of Health and Human Services, Public Health Service, Agency for Healthcare Research and Quality

3
by Lachance, Chantelle, Frey, Nina
Published 2020
Canadian Agency for Drugs and Technologies in Health
Subjects: ...Treatment Outcome...

4
Published 2021
World Health Organization
... global public health guidance on the initiation of treatment (with pharmacological agents...

5
by Shekelle, Paul G.
Published 2004
Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services

6
Published 2020
Swedish Agency for Health Technology Assessment and Assessment of Social Services (SBU)

8
Published 2009
World Health Organization

9
by Ninot, Gregory
Published 2021
Springer International Publishing
Table of Contents: ...Preface -- Chapter 1 - Definition of Non-Pharmacological Interventions (NPIs) -- Chapter 2...

10
Published 2023
Springer Nature Singapore
... agents used in the treatment of osteoporosis. It provides insight into mechanisms of action, updated...

11
by Gandorfer, Arnd
Published 2009
Karger
Subjects: ...Pharmacology...

12
Published 2016
Canadian Agency for Drugs and Technologies in Health
Subjects: ...Treatment Outcome...

13
by Kornør, Hege, Bjørndal, Arild, Welle-Strand, Gabrielle
Published 2006
Norwrgian Knowledge Centre for the Health Services
Subjects: ...Opiate Substitution Treatment / methods...

14
Published 2012
World Health Organization
Table of Contents: ...WHO guidelines on the pharmacological treatment of persisting pain in children with medical...

15
by McDonagh, Marian S.
Published 2020
Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services
...-specific adverse events led to withdrawal from treatment in some patients, suggesting that careful...

16
by McDonagh, Marian S.
Published 2020
Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services
...-specific adverse events led to withdrawal from treatment in some patients, suggesting that careful...

17
by Brasure, Michelle
Published 2013
Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services
...), "Preventive Pharmacologic Treatments for Migraine." The review was motivated by uncertainty around...

18
by Brasure, Michelle
Published 2013
Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services
Subjects: ...Treatment Outcome...

19
by Mans, Dennis R.A.
Published 2022
IntechOpen
... with antifungal potential and explains the phytochemical and pharmacological support for their apparent usefulness...

20
by Hutfless, Susan, Lau, Brandyn D., Wilson, Lisa M., Lazarev, Mark
Published 2014
Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services
...-intestinal manifestations when choosing a treatment strategy. However, no universal treatment strategy exists...